Comerica Bank’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $1.21M | Sell |
34,737
-2,141
| -6% | -$168K | ﹤0.01% | 1403 |
|
|
2025
Q3 | $3.06M | Sell |
36,878
-3,440
| -9% | -$249K | 0.01% | 936 |
|
|
2025
Q2 | $2.96M | Buy |
40,318
+2,494
| +7% | +$181K | 0.01% | 936 |
|
|
2025
Q1 | $4.32M | Sell |
37,824
-817
| -2% | -$49.7K | 0.02% | 741 |
|
|
2024
Q4 | $1.95M | Buy |
38,641
+600
| +2% | +$31.4K | 0.01% | 1156 |
|
|
2024
Q3 | $1.76M | Buy |
38,041
+7,200
| +23% | +$256K | 0.01% | 1215 |
|
|
2024
Q2 | $1M | Sell |
30,841
-1,754
| -5% | -$48K | ﹤0.01% | 1492 |
|
|
2024
Q1 | $821K | Sell |
32,595
-4,659
| -13% | -$110K | ﹤0.01% | 1643 |
|
|
2023
Q4 | $1.21M | Buy |
37,254
+203
| +0.5% | +$5.57K | 0.01% | 1440 |
|
|
2023
Q3 | $1.01M | Buy |
37,051
+8,079
| +28% | +$234K | 0.01% | 1451 |
|
|
2023
Q2 | $1 | Buy |
+28,972
| New | +$667K | ﹤0.01% | 641 |
|
|
2022
Q4 | $1.21M | Sell |
52,695
-16,145
| -23% | -$405K | 0.01% | 1353 |
|
|
2022
Q3 | $2M | Sell |
68,840
-8,570
| -11% | -$229K | 0.02% | 1041 |
|
|
2022
Q2 | $2.15M | Sell |
77,410
-370
| -0.5% | -$8.06K | 0.02% | 1056 |
|
|
2022
Q1 | $1.79M | Sell |
77,780
-1,975
| -2% | -$42K | 0.01% | 1224 |
|
|
2021
Q4 | $1.39M | Sell |
79,755
-10,142
| -11% | -$206K | 0.01% | 1384 |
|
|
2021
Q3 | $1.68M | Sell |
89,897
-3,477
| -4% | -$72.8K | 0.01% | 1405 |
|
|
2021
Q2 | $1.9M | Sell |
93,374
-8,087
| -8% | -$180K | 0.01% | 1336 |
|
|
2021
Q1 | $2.44M | Sell |
101,461
-3,602
| -3% | -$96.2K | 0.01% | 1240 |
|
|
2020
Q4 | $2.95M | Buy |
105,063
+257
| +0.2% | +$5.42K | 0.02% | 1049 |
|
|
2020
Q3 | $1.87M | Sell |
104,806
-303
| -0.3% | -$4.83K | 0.01% | 1170 |
|
|
2020
Q2 | $1.72M | Buy |
105,109
+5,237
| +5% | +$73.6K | 0.01% | 1179 |
|
|
2020
Q1 | $1.31M | Buy |
99,872
+3,432
| +4% | +$42.5K | 0.01% | 1175 |
|
|
2019
Q4 | $1.26M | Buy |
96,440
+772
| +0.8% | +$10.7K | 0.01% | 1408 |
|
|
2019
Q3 | $1.35M | Sell |
95,668
-2,501
| -3% | -$30.7K | 0.01% | 1344 |
|
|
2019
Q2 | $1.05M | Sell |
98,169
-5,151
| -5% | -$57.4K | 0.01% | 1507 |
|
|
2019
Q1 | $1.26M | Buy |
103,320
+1,561
| +2% | +$19.4K | 0.01% | 1435 |
|
|
2018
Q4 | $1.19M | Sell |
101,759
-460
| -0.5% | -$6.08K | 0.01% | 1441 |
|
|
2018
Q3 | $1.25M | Sell |
102,219
-41,264
| -29% | -$577K | 0.01% | 1459 |
|
|
2018
Q2 | $1.99M | Buy |
143,483
+43,464
| +43% | +$756K | 0.01% | 1267 |
|
|
2018
Q1 | $1.82M | Buy |
100,019
+2,812
| +3% | +$52.1K | 0.01% | 1285 |
|
|
2017
Q4 | $2.44M | Buy |
+97,207
| New | +$1.76M | 0.02% | 1142 |
|
Other funds holding CORT
ISL
PA
Comerica Bank's CORT Position: Q4 2025 in Review
Comerica Bank reduced its Corcept Therapeutics (CORT) stake by 5.8% in Q4 2025, selling an estimated $168K and leaving 34,737 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #1403.
Comerica Bank first reported a position in CORT in Q4 2017 and has held it in 32 quarters since. The position peaked at $4.32M in Q1 2025. 389 funds tracked by Wall St. Rank hold CORT as of Q4 2025.
- Comerica Bank held 34,737 shares of Corcept Therapeutics worth $1.21M as of Q4 2025.
- Comerica Bank sold 2,141 Corcept Therapeutics shares in Q4 2025, an estimated $168K.
- Corcept Therapeutics made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #1403 holding.
- Comerica Bank first reported a position in Corcept Therapeutics in Q4 2017 and has held it in 32 quarters since.
- Comerica Bank's Corcept Therapeutics position peaked at $4.32M in Q1 2025.
- 389 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q4 2025.
Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.